Jeffrey F. Eisenberg
Chief Executive Officer chez XENETIC BIOSCIENCES, INC.
Fortune : 1 572 $ au 31/03/2024
Profil
Mr. Jeffrey F.
Eisenberg is a Chief Executive Officer & Director at Xenetic Biosciences, Inc. He is on the Board of Directors at Xenetic Biosciences, Inc. Mr. Eisenberg was previously employed as an Independent Director by MabVax Therapeutics Holdings, Inc., a President by Novogyne Pharmaceuticals, a President, Chief Executive Officer & Director by Noven Pharmaceuticals, Inc., a General Counsel by IVAX Corp., and a Lawyer by Steel Hector & Davis LLP.
He also served on the board at MabVax Therapeutics, Inc. He received his undergraduate degree from The Wharton School of the University of Pennsylvania and a graduate degree from Columbia Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/12/2023 | 417 ( 0,03% ) | 1 572 $ | 31/03/2024 |
Postes actifs de Jeffrey F. Eisenberg
| Sociétés | Poste | Début |
|---|---|---|
| XENETIC BIOSCIENCES, INC. | Chief Executive Officer | 26/10/2017 |
Anciens postes connus de Jeffrey F. Eisenberg
| Sociétés | Poste | Fin |
|---|---|---|
| MABVAX THERAPEUTICS HOLDINGS, INC. | Director/Board Member | 31/07/2018 |
Noven Pharmaceuticals, Inc.
 Noven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL. | Chief Executive Officer | 01/01/2016 |
Novogyne Pharmaceuticals
 Novogyne Pharmaceuticals Pharmaceuticals: MajorHealth Technology Novogyne Pharmaceuticals manufactures pharmaceutical products. | President | 01/08/2014 |
IVAX LLC
 IVAX LLC Pharmaceuticals: MajorHealth Technology IVAX LLC discovers, develops, manufactures, and markets generic pharmaceuticals, respiratory drugs, and cancer treatments. It offers drugs for the treatment of multiple sclerosis, brain cancer, asthma, and epilepsy. The company was founded by Phillip Frost and Jane H. Hsiao in 1987 and is headquartered in Weston, FL. | General Counsel | - |
MabVax Therapeutics, Inc.
 MabVax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology MabVax Therapeutics, Inc. developed and commercialized immunotherapeutics for the treatment of cancer. The company was founded in 2006 and is headquartered in San Diego, CA. | Director/Board Member | - |
Formation de Jeffrey F. Eisenberg
| Columbia Law School | Graduate Degree |
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| XENETIC BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
IVAX LLC
IVAX LLC Pharmaceuticals: MajorHealth Technology IVAX LLC discovers, develops, manufactures, and markets generic pharmaceuticals, respiratory drugs, and cancer treatments. It offers drugs for the treatment of multiple sclerosis, brain cancer, asthma, and epilepsy. The company was founded by Phillip Frost and Jane H. Hsiao in 1987 and is headquartered in Weston, FL. | Health Technology |
Noven Pharmaceuticals, Inc.
Noven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL. | Health Technology |
MabVax Therapeutics, Inc.
MabVax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology MabVax Therapeutics, Inc. developed and commercialized immunotherapeutics for the treatment of cancer. The company was founded in 2006 and is headquartered in San Diego, CA. | Health Technology |
Steel Hector & Davis LLP
 Steel Hector & Davis LLP Miscellaneous Commercial ServicesCommercial Services Part of Squire Patton Boggs (US) LLP, Steel Hector & Davis LLP provides legal services. The private company is based in Miami, FL. Steel Hector & Davis was acquired by Squire Sanders (US) LLP on September 06, 2005. | Commercial Services |
MabVax Therapeutics Holdings, Inc.
 MabVax Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology MabVax Therapeutics Holdings, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. The company was founded on July 8, 2014 and is headquartered in San Diego, CA. | Health Technology |
Novogyne Pharmaceuticals
Novogyne Pharmaceuticals Pharmaceuticals: MajorHealth Technology Novogyne Pharmaceuticals manufactures pharmaceutical products. | Health Technology |
